ADIPOQ and hepatocellular carcinoma: Similarly, a recent meta-analysis of 13 studies including 1156 HCC patients (mostly patients with viral-associated HCC) and 2363 cancer-free controls (mainly healthy controls or patients with viral-related cirrhosis) reported a higher level of circulating adiponectin in HCC patients versus controls [72].